Gordon L Fung is a Clinical Professor of Medicine in the Clinical Health Sciences Tract. In addition to an active clinical practice in consultative general clinical cardiology, he also am medical director of the Electrocardiography Lab at Moffit/Long Hospitals, and the nation's first UCSF Asian Heart & Vascular Center located on the Mount Zion Campus on the 2nd floor of the Hellman Building.
Gordon L Fung research interests are in health disparities primarily involving the Asian/Pacific Islander populations as well as clinical hypertension and prevention. He currently PI of two Phase III industry sponsored trials with Roche Labs. The first one is with dalcetrapib - a CETP inhibitor that can raise HDL-Cholesterol in the ACS patient. The second is ALECARDIO which is evaluating a combined-balanced ppar alpha/gamma agent in type 2 diabetic patients presenting with ACS to the hospital.
